Circulating MicroRNA Markers for Pulmonary Hypertension in Supervised Exercise Intervention and Nightly Oxygen Intervention

Circulating MicroRNA Markers for Pulmonary Hypertension in Supervised Exercise Intervention and Nightly Oxygen Intervention

Rationale: Therapeutic exercise training has been shown to significantly improve pulmonary hypertension (PH), including 6-min walking distance and right heart function. Supplemental nightly oxygen also has therapeutic effects. A biomarker tool that could query critical gene networks would aid in und...

Full description

Bibliographic Details
Main Authors:	Gabriele Grunig, Christina A. Eichstaedt, Jeremias Verweyen, Nedim Durmus, Stephanie Saxer, Greta Krafsur, Kurt Stenmark, Silvia Ulrich, Ekkehard Grünig, Serhiy Pylawka
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-07-01
Series:	Frontiers in Physiology
Subjects:	pulmonary hypertension MicroRNA circulating biomarker high altitude pulmonary hypertension supervised exercise training nightly oxygen intervention
Online Access:	https://www.frontiersin.org/article/10.3389/fphys.2018.00955/full

Similar Items

Rehabilitation in patients with pulmonary arterial hypertension
by: Stephan Keusch, et al.
Published: (2017-07-01)

Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri®): a prospective, 6-months, open label, observational, non-interventional study
by: Julia Degering, et al.
Published: (2023-01-01)

Right Heart Size and Right Ventricular Reserve in Pulmonary Hypertension: Impact on Management and Prognosis
by: Ekkehard Grünig, et al.
Published: (2020-12-01)

<i>BMPR2</i> Promoter Variants Effect Gene Expression in Pulmonary Arterial Hypertension Patients
by: Jie Song, et al.
Published: (2020-10-01)

The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR)
by: Cima Katharina, et al.
Published: (2012-09-01)

Resistin-like Molecule α and Pulmonary Vascular Remodeling: A Multi-Strain Murine Model of Antigen and Urban Ambient Particulate Matter Co-Exposure
by: Nedim Durmus, et al.
Published: (2023-07-01)

Cardiorespiratory Adaptation to Short-Term Exposure to Altitude vs. Normobaric Hypoxia in Patients with Pulmonary Hypertension
by: Simon R. Schneider, et al.
Published: (2022-05-01)

A novel clinical prediction scoring system of high-altitude pulmonary hypertension
by: Yanxi Zeng, et al.
Published: (2024-01-01)

Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study
by: Christina A. Eichstaedt, et al.
Published: (2020-05-01)

Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up
by: Panagiota Xanthouli, et al.
Published: (2020-05-01)

Right Atrial Pressure During Exercise Predicts Survival in Patients With Pulmonary Hypertension
by: Mona Lichtblau, et al.
Published: (2020-11-01)

Pre-clinical assessment of a water-in-fluorocarbon emulsion for the treatment of pulmonary vascular diseases
by: Scott K. Ferguson, et al.
Published: (2019-01-01)

Inflammation in Pulmonary Hypertension and Edema Induced by Hypobaric Hypoxia Exposure
by: Samia El Alam, et al.
Published: (2022-10-01)

Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension
by: Pfarr Nicole, et al.
Published: (2013-01-01)

Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension
by: Panagiota Xanthouli, et al.
Published: (2021-11-01)

Reduction of <i>BMPR2</i> mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?
by: Vivienne Theobald, et al.
Published: (2022-04-01)

Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trial
by: Eglė Palevičiūtė, et al.
Published: (2023-04-01)

Profiles and treatment patterns of patients with pulmonary arterial hypertension on monotherapy at experienced centres
by: Max Wissmüller, et al.
Published: (2022-10-01)

Comorbidities of Patients With Idiopathic Pulmonary Fibrosis in Four Latin American Countries. Are There Differences by Country and Altitude?
by: Mauricio Gonzalez-Garcia, et al.
Published: (2021-06-01)

Interventional and Surgical Treatments for Pulmonary Arterial Hypertension
by: Tomasz Stącel, et al.
Published: (2021-07-01)

Surgical and Device Interventions in the Treatment of Chronic Thromboembolic Disease
by: Hayah Kassis-George, et al.
Published: (2023-02-01)

Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension
by: R. James White, et al.
Published: (2019-09-01)

AMPK and the Challenge of Treating Hypoxic Pulmonary Hypertension
by: Karen Flores, et al.
Published: (2022-06-01)

Cinaciguat (BAY-582667) Modifies Cardiopulmonary and Systemic Circulation in Chronically Hypoxic and Pulmonary Hypertensive Neonatal Lambs in the Alto Andino
by: Felipe A. Beñaldo, et al.
Published: (2022-06-01)

Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis
by: Panagiota Xanthouli, et al.
Published: (2022-07-01)

Recent trends in pulmonary arterial hypertension
by: Rajagopalan Natarajan
Published: (2011-01-01)

Pulmonary Endarterectomy in Latvia: A National Experience
by: Matiss Sablinskis, et al.
Published: (2019-01-01)

Favorable Pregnancy Outcomes in Women With Well-Controlled Pulmonary Arterial Hypertension
by: Nadine Corbach, et al.
Published: (2021-07-01)

Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes
by: Lixia Wang, et al.
Published: (2023-04-01)

Thin Air, Thick Vessels: Historical and Current Perspectives on Hypoxic Pulmonary Hypertension
by: Jason M. Young, et al.
Published: (2019-05-01)

Brief Report: Case Comparison of Therapy With the Histone Deacetylase Inhibitor Vorinostat in a Neonatal Calf Model of Pulmonary Hypertension
by: Tanya J. Applegate, et al.
Published: (2021-09-01)

Percutaneous Interventional Therapy for Chronic Thromboembolic Pulmonary Hypertension
by: Ehtisham Mahmud, MD, et al.
Published: (2023-03-01)

Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry
by: I E Chazova, et al.
Published: (2019-01-01)

Pulmonary hypertension due to left upper lobe partial anomalous pulmonary venous return
by: Semi Öztürk, et al.
Published: (2016-12-01)

Disease characteristics and clinical outcome over two decades from the Swiss pulmonary hypertension registry
by: Paula Appenzeller, et al.
Published: (2022-01-01)

Correlation of ECG changes at high altitude with findings on Coronary Angiogram.
by: Mohsin Saif, et al.
Published: (2022-11-01)

Oxidative Stress and Diseases Associated with High-Altitude Exposure
by: Eduardo Pena, et al.
Published: (2022-01-01)

Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
by: Coons JC, et al.
Published: (2023-07-01)

Brazilian Thoracic Society recommendations for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension
by: Caio Julio Cesar dos Santos Fernandes, et al.
Published: (2022-06-01)

Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease
by: Chau Le Bao Ho, et al.
Published: (2022-10-01)